Sort
78,016 grants matching “breast cancer”
Center of Excellence for Cancer Research, Training and Community Service
$1,109,043Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · P20 · FY2015 · MD
Strategies for Cancer Immunotherapy Clinical Trials
$1,107,978Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,107,978Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Finding Sleeping Beauty: T Cell Biosensors for Dormant Cancer Detection
$1,107,400Gabriel A Kwong · Georgia Institute Of Technology · DP1 · FY2022 · CA
Finding Sleeping Beauty: T Cell Biosensors for Dormant Cancer Detection
$1,107,400Gabriel A Kwong · Georgia Institute Of Technology · DP1 · FY2023 · CA
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
$1,107,095Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
An Off-the-Shelf tumor cell vaccine with HLA-matching alleles for personalized treatment of advanced metastatic prostate cancer.
$1,106,781William Valentine Williams · Briacell Therapeutics Corp · R44 · FY2025 · CA
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
$1,106,638Thomas E Rohan · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,106,459Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2023 · CA
Maternal And Fetal Drug Exposure Alteration in Pregnancy
$1,106,289University Of Washington · P50 · FY2002 · HD
Project 3: Characterization of the biology of non-responders using Imaging and molecular analysis to inform treatment
$1,106,270Laura J Van't Veer · University Of California, San Francisco · P01 · FY2025 · CA
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models
$1,106,205Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Bastyr/UW Oncomycology Translational Research Center
$1,106,200Leanna J Standish · Bastyr University · U19 · FY2011 · AT
Growth Factor Receptor in Breast Cancer Progression and Metabolic Regulation
$1,106,159Mien-Chie Hung · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
COHORT STUDY OF DIETARY SUPPLEMENTS AND CANCER RISK
$1,106,093Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - CCC (Lead)
$1,106,076Steven M Kawut · University Of Pennsylvania · R01 · FY2019 · HL
Targeted Discovery of Marine-derived Anticancer Leads
$1,105,895Phil Crews · University Of California Santa Cruz · U19 · FY2007 · CA
MEMBRANE TRAFFIC IN NORMAL AND TRANSFORMED CELLS
$1,105,691Yale University · P01 · FY2002 · CA
GROWTH FACTOR RECEPTOR SIGNALING IN BREAST CANCER
$1,105,570University Of Texas Md Anderson Can Ctr · P01 · FY2003 · CA
Clinical Trials and Information Management Support
$1,105,279Donald Stablein · The Emmes Company, Llc · N02 · FY2010 · CA
UNC-CH Nutrition Obesity Research Center
$1,105,125Steven H Zeisel · Univ Of North Carolina Chapel Hill · P30 · FY2012 · DK
UNC-CH Nutrition Obesity Research Center
$1,104,990Steven H Zeisel · Univ Of North Carolina Chapel Hill · P30 · FY2015 · DK
Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial
$1,104,814Loic Le Marchand · University Of Hawaii At Manoa · R01 · FY2021 · CA
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI
$1,104,692George Washington University · N01 · FY2000 · WH
Genetic Epidemiology
$1,104,644Alisa Goldstein · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA